Iterum Therapeutics Plc (ITRM) Tops Q4 EPS by 63c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q4 EPS of ($0.52), $0.63 better than the analyst estimate of ($1.15).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Sharon AI surges premarket; New Oriental gains, Medline slips
• UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist